首页> 外国专利> Bladder drop infusion composition with increased storage stability for the treatment of cystitis and containing chondroitin sulfate (4.5 MG / ML), hyaluronic acid (16 MG / ML) and phosphate buffer (PH 6.1 to 7.9)

Bladder drop infusion composition with increased storage stability for the treatment of cystitis and containing chondroitin sulfate (4.5 MG / ML), hyaluronic acid (16 MG / ML) and phosphate buffer (PH 6.1 to 7.9)

机译:具有增加的储存稳定性的膀胱滴剂输注组合物,用于治疗膀胱炎,并且包含硫酸软骨素(4.5毫克/毫升),透明质酸(16毫克/毫升)和磷酸盐缓冲液(PH 6.1至7.9)

摘要

The present invention provides chondroitin sulfate (4.5 mg / ml), hyaluronic acid (16 mg / ml), phosphate buffer (pH 6.1 to 7.9) and electrolytes for urogenital, in particular for the treatment of inflammation of the bladder, in particular for the treatment of cystitis. For example, the present invention relates to combination drugs with increased storage stability, which contain alkaline salts such as sodium chloride, and drip infusion kits containing the drug.
机译:本发明提供了硫酸软骨素(4.5mg / ml),透明质酸(16mg / ml),磷酸盐缓冲剂(pH 6.1至7.9)和用于泌尿生殖器的电解质,所述电解质特别用于治疗膀胱的炎症,特别是用于膀胱炎症。膀胱炎的治疗。例如,本发明涉及具有增加的储存稳定性的组合药物,其包含碱性盐例如氯化钠,以及包含该药物的滴注套件。

著录项

  • 公开/公告号KR20200003015A

    专利类型

  • 公开/公告日2020-01-08

    原文格式PDF

  • 申请/专利权人 화르코-파르마 게엠베하;

    申请/专利号KR20197034864

  • 发明设计人 마이어 안드레아스;

    申请日2018-05-02

  • 分类号A61K9/08;A61K31/728;A61K31/737;A61K47/02;A61K9;A61P13/10;A61P29;

  • 国家 KR

  • 入库时间 2022-08-21 11:08:07

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号